Navigation Links
Ambion Custom


All Ambion reagents, enzymes, and kits are available in bulk sizes
Bulk packaging reduces costs and conserves time and resources
Stringent quality control is guaranteed

Figure 1. Crystals of Group I Intron From Bacteriophage Twort.


Today's laboratory demands often require products and services that fall outside the range of standard kit configurations and sizes from typical life science reagent companies. Specialized protocols may quickly consume reagents in large volumes. For these situations, Ambion's kits, reagents, and enzymes are all available in bulk sizes that can save both time and resources.

Our most popular bulk-sized kits include:

5X MEGAscript High Yield Transcription Kit,
5X MessageAmp II aRNA Kit for RNA amplification for array analysis
5X mMESSAGE mMACHINE High Yield Capped RNA Transcription Kit.


5X MEGAscript Kit Enables Efficient Crystallography

Dr. Barbara Golden's laboratory (Purdue University) used Ambion's 5X MEGAscript High Yield Transcription Kit to transcribe milligram quantities of RNA--3.75 mg purified group I intron from bacteriophage Twort--for crystallography (Figure 1). The superior performance of this kit led to increased product concentrations, which reduced sample volumes and improved the efficiency of subsequent purification steps. Three to five mg/ml RNA generated with this bulk reagent kit allows production of 250-1000 crystallization drops for X-ray crystallography.

To find out how Ambion can help meet your specific research requirements, email us at custom@ambion.com. R&D and production scientists are available to plan and design products specifically for your applications.


back to top


Ordering Information Cat# Product Name Size B1334-5 5X MEGAscript T7 Kit 200 rxns B1345-5 5X mMESSAGE mMACHINE T7 ULTRA Kit 50 rxns B1751-5 5X MessageAmp II aRNA Amplification Kit 100 rxns
'"/>

Source:


Page: All 1 2

Related biology technology :

1. Ambion Custom: Made-to-Order
2. Ambion Offers Gene Expression Profiling Service
3. Matched siRNAs and Assays: Ambion + Applied Biosystems = RNAi Success
4. Your Data: Detection of Oocyte-specific Gene Expression Using Ambions Cells-to-cDNA Kit
5. Custom and library siRNA for efficient gene silencing
6. Custom and library siRNA for efficient gene silencing
7. Custom siRNA Oligo Synthesis Service
8. Custom RNA & RNA Isolation Services to Meet Your Specific Needs
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/2/2016)... ... December 01, 2016 , ... ... demonstrating the value of DNA microarray comparative genomic hybridization (array CGH) for ... Breast Cancer Symposium. Using molecular test results from tumors with previously documented ...
(Date:12/2/2016)... ... , ... DrugDev believes the only way to achieve real change ... three tenets were on display at the 2nd Annual DrugDev User Summit (hosted by ... and site organizations to discuss innovation and the future of clinical research. , ...
(Date:12/2/2016)... YORK , Dec. 1, 2016   SurePure, ... photopurification, announced today that the Company has concluded an ... the right for a 90-day period to acquire units ... value of approximately USD 3.7 million.  ... agreement with Tamarack under which Tamarack will seek regulatory ...
(Date:11/30/2016)... 2016  GenomOncology today announced the appointment of Joshua ... Dr. Coleman will oversee clinical content development ... platform. The GenomOncology software suite empowers molecular pathologists with a ... clinical decision support, from quality control through reporting. ... , , ...
Breaking Biology Technology:
(Date:11/22/2016)... MINNETONKA, Minn. , Nov. 22, 2016   ... that supports the entire spectrum of clinical research, is ... by Medical LiveWire Healthcare and Life Sciences Awards ... This award caps off an unprecedented year of recognition ... clinical trials for over 15 years. iMedNet ...
(Date:11/17/2016)... -- Global Market Watch: Primarily supported by ownership ... and Academics) market is to witness a value of US$37.1 ... highest Compounded Annual Growth Rate (CAGR) of 10.75% is foreseen ... period 2014-2020. North America is not ... Europe at 9.56% respectively. Report Focus: ...
(Date:11/15/2016)... ROCKVILLE, Md. , Nov. 15, 2016 /PRNewswire/ ... clinical company developing therapeutics focused on the gut ... public offering of 25,000,000 shares of its common ... its common stock at a price to the ... gross proceeds to Synthetic Biologics from the offering, ...
Breaking Biology News(10 mins):